Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00095706
Status:
COMPLETED
Last Update Posted:
2015-09-25
First Post:
2004-11-05
Brief Title:
Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab Antibodies Against HER2 and VEGF
Sponsor:
Translational Oncology Research International
Organization:
Translational Oncology Research International
Organization Data
Organization:
Translational Oncology Research International
Class:
OTHER
Study ID:
TORI B-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Translational Oncology Research International
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Sara Hurvitz
Old Organization:
University of California Los Angeles
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |